The trajectory of Sildenafil presents a complex picture for investors. While the initial introduction generated substantial gains, the end of its patent opened the avenue to off-brand versions, dramatically eroding https://zbookmarkhub.com/story21806108/viagra-and-big-pharma-a-precarious-opportunity